市場調查報告書
商品編碼
1535179
硬腦膜替代市場:各市場區隔規模,佔有率,法律規章,償付,手術,2033年為止的預測Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
硬腦膜材料是用來修復硬腦膜的片材或材質的補片。閉合或修復硬腦膜對於防止腦脊髓液(CSF)滲漏至關重要。本部分追蹤生物和合成硬腦膜替代品。
硬腦膜撕裂是開顱手術和脊椎融合手術的風險。修復不充分會導致腦脊髓液漏、感染和神經損傷。小的撕裂可以透過止血來閉合,但較大的撕裂需要硬腦膜替代物。硬腦膜替代物在開顱手術中比在脊椎介入治療中更常用。
本報告提供全球硬腦膜替代市場相關資料詳細考察,提供市場上競爭情形,SWOT分析,到2033年為止的市場預測,地區,各國的趨勢等資訊。
Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.
These are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a cerebrospinal fluid (CSF) leak. Biological dura substitutes and synthetic dura substitutes are tracked under this segment.
Dural tears are a risk in craniotomy and spinal fusion surgeries. Inadequate repair can lead to cerebrospinal fluid leakage, infection, and neurological deficits. Small tears are closed watertight, while larger ones require dura substitutes. Dura substitutes are more commonly used in craniotomy procedures than in spinal interventions.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Dura Substitutes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Integra LifeSciences Corp, B. Braun Melsungen AG, Medtronic Plc, DePuy Synthes Inc, Regenity Biosciences, Baxter International Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -